Generalized vaccinia, progressive vaccinia, and eczema vaccinatum are rare following smallpox (vaccinia) vaccination: United States surveillance, 2003

Clinical Infectious Diseases

Volumn 41, Issue 5, 2005, Pages 689-697

  Vellozzi, Claudia ^a,c,f   Lane, J Michael ^f   Averhoff, Francisco ^a   Maurer, Toby ^d   Norton, Scott ^e   Damon, Inger ^b   Casey, Christine ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Logistics Health Incorporated   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BIOLOGICAL WARFARE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; ECZEMA; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERSENSITIVITY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SMALLPOX; SMALLPOX VIRUS; UNITED STATES; VACCINIA; VACCINIA VIRUS; VIRUS CULTURE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SMALLPOX VACCINE; UNITED STATES; VACCINIA;

EID: 23844484884     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432584     Document Type: Article

References (29)

1. Department of Health and Human Services. Declaration regarding administration of smallpox countermeasures. Federal Register 2003; 68:4212-3. Available at: http://www.gpoaccess.gov/fr/. Accessed 21 July 2005.
2. Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA 2003; 289:3278-82.
3. Rotz LD, Dotson DA, Damon IK, Becher JA. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. ACIP. MMWR Recomm Rep 2001; 50:1-25.
4. Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions: guidance for clinicians. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52:1-28.
5. Neff JM, Levine RH, Lane JM, et al. Complications of smallpox vaccination: United States 1963. II. Results obtained by four statewide surveys. Pediatrics 1967; 39:916-23.
6. Neff JM, Lane JM, Pert JH, et al. Complications of smallpox vaccination. I. National survey in the United States, 1963. N Engl J Med 1967; 276:125-32.
7. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: national surveillance in the United States. N Engl J Med 1969; 281:1201-8.
8. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results often statewide surveys. J Infect Dis 1970; 122:303-9.
9. Fulginiti VA, Kempe CH, Hathaway WE, et al. Progressive vaccinia in immunologically deficient individuals. In: Good R, ed. Immunologic diseases of man. Birth Defects Original Article Series, Vol 4. New York: National Foundation March of Dimes, 1968:129-51.
10. Kempe CH. Studies on smallpox and complications of smallpox vaccination: E. Mead Johnson Award address. Pediatrics 1960; 26:176-89.
11. Fulginiti VA, Papier A, Lane MJ, Neff JM, Herderson DA. Smallpox vaccination: a review, part II: adverse events. Clin Infect Dis 2003; 37:251-71.
12. Copeman PWW, Wallace HJ. Eczema vaccinatum. Br Med J 1964; 5414:906-8.
13. Chen RT, Rastogi SC, Mullen JR. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994; 12:542-50.
14. Kipreos V. Transcript: data and information management of the smallpox vaccine program, 2002. Available at: http://www.bt.cdc.gov/agent/ smallpox/training/webcast/dec2002. Accessed 5 May 2004.
15. Kelly CD, Egan C, Davis SW, et al. Laboratory confirmation of generalized vaccinia following smallpox vaccination. J Clin Microbiol 2004; 42:1373-5.
16. Wharton M, Strikas RA, Harpaz R, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52:1-16.
17. Aragon TJ, Ulrich S, Fernyak S, Rutherford GW. Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968. BMC Public Health 2003; 3:26.
18. Greenberg RN, Schosser RH, Plummer EA, et al. Urticaria, exanthems, and other benign dermatologic reactions to smallpox vaccination in adults. Clin Infect Dis 2004; 38:958-65.
19. Talbot TR, Bredenberg HK, Smith M, et al. Focal and generalized folliculitis following smallpox vaccination among vaccinia-naïve recipients. JAMA 2003; 289:3290-4.
20. Angulo JJ, De Salles-Gomes LF, De Britto T, et al. Observations on vaccinial eruptions and differential diagnosis of generalized vaccinia. Postgrad Med J 1962; 38:145-9.
21. Kennedy JS, Frey SE, Yan L, et al. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. J Infect Dis 2004; 190:1286-94.
22. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia-transmission of vaccinia from smallpox vaccination. JAMA 2002; 288:1901-5.
23. Eriksson G, Forsbeck M. Smallpox outbreak and vaccination problems in Stockholm, Sweden, 1963: the assessment and the vaccination of patients with cutaneous disorders. Acta Med Scand Suppl 1966; 464:147-57.
24. Dewar WA, Finn GA. Vaccination in the presence of skin diseases: results in eighty-four cases. Glasgow Med J 1954; 35:141-4.
25. Engler RJ, Kenner J, Leung DY. Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 2002; 110:357-65.
26. Schultz-Larsen F, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002; 1:22.
27. Taylor B, Wadsworth M, Wadsworth J, Peckham C. Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 1984; 2:1255-7.
28. Williams HC. Is the prevalence of atopic dermatitis increasing: Clin Exp Dermatol 1992; 17:385-91.
29. Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 2004; 428:182-5.